MAETRICS™ > Compliance.Quality.Technology

Maetrics™ is prepared to quickly deploy a team of professionals to implement the changes necessary to comply with the new MDD 2007/47/EC (M5) regulations. Through the utilization of proven methodologies and tools, medical device manufacturers can rest assured that their products will maintain compliance with CE Marking requirements, and can thus remain focused on crucial day‐to‐day operations without interruption.

Indiana Medical Device Manufacturers Council has set its annual meeting for October 22nd 2009. Maetrics™ will be exhibiting to present new information on its Lean Compliance System™ to industry associates.

FDA commissioner Margaret Hamburg, MD places strong renewed emphasis on the necessity of FDA compliance for manufacturers. New initiatives will expedite the process of warning letter issuance, and will come with steeper penalties in order to bolster confidence in public health initiatives.

Lean Compliance Program Management for FDA regulated industries medical device pharmaceutical biotechnology

Maetrics has recently initiated a research study on understanding and preparations for the upcoming transition to the European Authority\\\'s MDD 2007 that is set to take effect on March 21, 2010.

Maetrics is pleased to announce the new appointment of Patrick Baker as the Vice President of Operations.

Maetrics is pleased to offer New Desktop Compliance Reference Guides that relate to both the Pharmaceutical and Medical Device industries. These guides were developed by Maetrics professionals to provide quality and regulatory personnel in these respective industries with an intuitively designed tool to access the most important compliance guidelines pertaining to them.